2 July 2020:
Tiny structures called nanocages have the potential to revolutionise treatment of conditions like Parkinson’s and Alzheimer’s diseases.
Two researchers, seemingly worlds apart: one a nanoscientist, the other a neuroscientist. Born in different hemispheres with labs in different states, at the start of their game-changing collaboration 2 years ago, they felt they were speaking different languages.
21 Feb 2020:
For Dr Andrew Care, tiny structures inside living bacteria may hold the key to tackling many diseases. Shaped like miniature soccer balls, these protein nanocages can be modified to accomplish a wide range of tasks, from helping microbes cope with environmental stress to delivering drug payloads inside cancer cells. Continue reading
22 February 2019:
CNBP Associate Investigators Dr Lyndsey Collins-Praino (University of Adelaide) and Dr Andrew Care (Macquarie University) together with CNBP Director Prof. Mark Hutchinson have been awarded a highly competitive Research Grant by the NeuroSurgical Research Foundation. The funds will help the team to work on pioneering a novel nanotechnology that will look to prevent the spread of Parkinson’s Disease throughout the human brain.
30 October 2018:
CNBP Associate Investigators Dr Lyndsey Collins-Praino (University of Adelaide) and Dr Andrew Care (Macquarie University), together with CNBP Director Prof Mark Hutchinson have been awarded a highly competitive Research Gift by the Australian Brain Foundation.
The funds granted will help the team to develop a new technique that aims to prevent the spread of Parkinson’s Disease in the human brain.
Below: Dr Lyndsey Collins-Praino and Dr Care accept their Research Award (with Prof Hutchinson in absentia).